More and more states are legalizing medical and recreational use of marijuana. Because of this and other factors, the value of the industry is exploding. Some estimates are predicting the value to hit $22 billion worldwide by 2022. This relatively new industry provides investors with a potentially great opportunity. Marijuana and CBD investing is a fresh avenue to take advantage of new, high growth markets.
One company at the forefront of this ballooning market is Canopy Growth Corp, which is headquartered in Canada. This early contender has quickly become the largest publicly traded weed company. Their products include both medical and recreational strains of CBD. In 2019, the company’s revenues hit about $60 million USD. This number is leagues ahead of many competitors.
Another competitive advantage that Canopy Growth has is its relationship with Constellation Brands, the maker of Corona Beer. Constellation initiated the relationship by buying a 9.9% stake in Canopy Growth back in October of 2017. Since then, they’ve doubled down and invested an additional $4 billion to bring their stake up to 40%. This partnership opens up a great chance for Canopy to venture into cannabis infused beverages. A market which is thought to likely become significantly successful.
Investing in CBD is just one exciting growth opportunity. As a forward thinking and proactive investment firm, we’ll work with you to identify important trends that you can capitalize on to earn greater returns on your money. If you’re interested in learning more about investing in CBD and Marijuana, please contact us! We’d be happy to share our ideas with you and discuss other recent developments.
